![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.36 | 23.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/3/2023 21:10 | Yep, She Almighty has a great laugh at Eden's RNSs. | ![]() neutralpov | |
01/3/2023 15:19 | Si vis Deum facere risum, indica illis tua consilia. | ![]() supersonico | |
01/3/2023 11:41 | Vanguard’s CEO Bucks the ESG Orthodoxy Tim Buckley pulls out of the Net Zero Managers initiative and affirms his fiduciary duty to clients. | ![]() supersonico | |
01/3/2023 08:02 | As we move further north of 0p t. | ![]() supersonico | |
26/2/2023 20:58 | H---o-o-i-- | ![]() supersonico | |
25/2/2023 20:41 | Yeah, and Viagra is on the rise too. Hard facts. | ![]() neutralpov | |
25/2/2023 10:57 | SustainE takes the elevator. | ![]() supersonico | |
23/2/2023 21:55 | As we move further south to 0p th. | ![]() neutralpov | |
23/2/2023 12:26 | What's your timeframe Neuts? | ![]() timbo_slice | |
23/2/2023 11:01 | SPACE.. will unlock the powder of the seeds. | ![]() supersonico | |
23/2/2023 07:57 | I'm not sure you can still say this .... 0p reiterations did become less frequent as we "climbed" from 4 to 6, but we are basically back at 4 pence.... | ![]() timbo_slice | |
23/2/2023 07:09 | As we move further north of 0p th. | ![]() supersonico | |
22/2/2023 21:00 | As we move further north of 0p the . | ![]() supersonico | |
22/2/2023 14:55 | hxxps://polaris.brig California state approval due and Eden's biggest market in the US Regulatory filing in the EU for the Eden/Corteva seed now due (with anticipated annual income of circa €40 million, initially getting to €20million p.a. Taken from previous RNS's) and anticipated approval for the 2024 growing season Also filing for selected additional territories, defacto US +++ US and EU distributor(s) to be appointed for Eden's (4 insect) insecticide Other seed treatments aside of Corteva being pursued It is very clear to see that in due course, not long from now and possibly in short order, Eden will show many millions in their income accounts and many millions as the bottom line on their P & L | ![]() investingisatrickygame | |
22/2/2023 11:12 | OK, for all you 'Hopium' addicts. This is the earnings season, global companies with multi billion turnovers are publishing accounts. Eden, with negligible sales, but hefty overhead, cannot manage this. Perhaps the CFO is wholly incompetent. Perhaps Eden cannot raise any more cash. Your choice, whilst there are still pence on the table. | ![]() ravenna23 | |
22/2/2023 08:30 | Investigating the effects of glyphosate on the bumblebee proteome and microbiota. | ![]() supersonico | |
22/2/2023 08:27 | Glyphosate based-herbicide disrupts energy metabolism and activates inflammatory response through oxidative stress in mice liver. | ![]() supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions